QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019

BACKGROUND: Observational studies have suggested increased arrhythmic and cardiovascular risk with the combination use of hydroxychloroquine (HCQ) and azithromycin in patients with coronavirus disease 2019 (COVID-19). OBJECTIVE: The arrhythmic safety profile of HCQ monotherapy, which remains under i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Heart Rhythm O2
Main Authors: Sridhar, Arun R., Chatterjee, Neal A., Saour, Basil, Nguyen, Dan, Starnes, Elizabeth A., Johnston, Christine, Green, Margaret L., Roth, Gregory A., Poole, Jeanne E.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020
Assuntos:
Clinical
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7289101/
https://ncbi.nlm.nih.gov/pubmed/32835316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hroo.2020.06.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados